Multicenter Evaluation of the Susceptibility of Enterobacteriaceae and Pseudomonas Aeruginosa to Ceftolozane/Tazobactam Combination
CompletedOBSERVATIONAL
Enrollment
747
Participants
Timeline
Start Date
March 1, 2019
Primary Completion Date
March 1, 2020
Study Completion Date
December 30, 2022
Conditions
Antibiotic Resistant Strain
Trial Locations (1)
75014
Groupe Hospitalier Paris Saint Joseph, Paris
All Listed Sponsors
lead
Fondation Hôpital Saint-Joseph
OTHER
NCT03963297 - Multicenter Evaluation of the Susceptibility of Enterobacteriaceae and Pseudomonas Aeruginosa to Ceftolozane/Tazobactam Combination | Biotech Hunter | Biotech Hunter